Circulating free plasma tumor DNA in patients with advanced gastric cancer receiving systemic chemotherapy-Reference-Cited by-同舟云学术

Circulating free plasma tumor DNA in patients with advanced gastric cancer receiving systemic chemotherapy

Published:2018-11-26 Issue:1 Volume:18 Page:
ISSN:1472-6890
Container-title:BMC Clinical Pathology
language:en
Short-container-title:BMC Clin Pathol

Author:

Normando Sávia Raquel Costa^ORCID,Delgado Pamela de Oliveira,Rodrigues Ana Katherine Soares Barbosa,David Filho Waldec Jorge,Fonseca Fernando Luiz Affonso,Cruz Felipe José Silva Melo,del Giglio Auro

Publisher

Springer Science and Business Media LLC

Subject

Histology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12907-018-0079-y.pdf

Reference15 articles.

1. Kamangar F, Dores GM, Anderson WF. Patterns of Cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce Cancer disparities in different geographic regions of the world. JCO. 2006;24:2137–50.

2. Lim L, Michael M, Mann GB, Leong T. Adjuvant therapy in gastric Cancer. JCO. 2005;23:6220–32.

3. Hamakawa T, Kukita Y, Kurokawa Y, Miyazaki Y, Takahashi T, Yamasaki M, Miyata H, Nakajima K, Taniguchi K, Takiguchi S, Mori M, Doki Y, Kato K. Monitoring gastric cancer progression with circulating tumour DNA. Br J Cancer. 2015;112:352–6.

4. Shimada H, Noie T, Ohashi M, Oba K, Takahashi Y. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the task force of the Japanese gastric Cancer association. Gastric Cancer. 2013;17(1):26–33.

5. Kim K, Shin DG, Park MK, Baik SH, Kim TH, Kim S, Lee SY. Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection. Ann Surg Treat Res. 2014;86(3):136–42.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-dimensional cell-free DNA-based liquid biopsy for sensitive early detection of gastric cancer;Genome Medicine;2024-06-07

2. Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay;International Journal of Clinical Oncology;2024-03-29

3. Clinical applications and perspectives of circulating tumor DNA in gastric cancer;Cancer Cell International;2024-01-06

4. Liquid Biopsy: An Emerging Diagnostic, Prognostic, and Predictive Tool in Gastric Cancer;Journal of Gastric Cancer;2024

5. Minimal residual disease (MRD) detection in solid tumors using circulating tumor DNA: a systematic review;Frontiers in Genetics;2023-08-10